Theravance Biopharma Inc - Company Profile
Powered by
All the data and insights you need on Theravance Biopharma Inc in one report.
- Save hours of research time and resources with
our up-to-date Theravance Biopharma Inc Strategy Report
- Understand Theravance Biopharma Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Theravance Biopharma Inc (Theravance Biopharma) is a diversified biopharmaceutical company that develops organ-selective medicines for the treatment of immune system disorders and inflammation. Focus on R&D, and marketed product: Yupelri, collaboration with Viatris are its strengths, even as a history of operating losses could be a cause for concern to the company. The company could benefit from the market potential of asthma, orphan drug designation and the market potential of Yupelri for the treatment of chronic obstructive pulmonary disease (COPD). However stringent regulations, stiff competition and reliance on third-party manufacturers could affect the company's growth.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer